- Conditions
- Schizophrenia
- Interventions
- RGH-188
- Drug
- Lead sponsor
- Forest Laboratories
- Industry
- Eligibility
- 18 Years to 65 Years
- Enrollment
- 375 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- Started 2006
- U.S. locations
- 1
- States / cities
- St Louis, Missouri
Search Results
Search by objective public record fields.
Search by query text, NCT ID, condition, intervention, sponsor, city, state, recruitment status, phase, study type, healthy volunteer eligibility, sex, or age. Results are retrieved from ClinicalTrials.gov and synchronized into the directory. Search pages remain noindex by default.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Showing 1–24
of 63
matching trials from the live ClinicalTrials.gov search.
Local D1 index available.
- Conditions
- Schizophrenia
- Interventions
- Cariprazine, Placebo
- Drug
- Lead sponsor
- Forest Laboratories
- Industry
- Eligibility
- 18 Years to 60 Years
- Enrollment
- 446 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2010 – 2011
- U.S. locations
- 15
- States / cities
- Costa Mesa, California • Long Beach, California • Paramount, California + 12 more
- Conditions
- Schizophrenia
- Interventions
- SB-773812, Olanzapine
- Drug
- Lead sponsor
- GlaxoSmithKline
- Industry
- Eligibility
- 18 Years to 65 Years
- Enrollment
- 338 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2005 – 2007
- U.S. locations
- 18
- States / cities
- Birmingham, Alabama • Cerritos, California • Garden Grove, California + 15 more
- Conditions
- Schizophrenia
- Interventions
- Lurasidone, Olanzapine, Placebo comparator, Lurasidone 40 mg tablets
- Drug
- Lead sponsor
- Sumitomo Pharma America, Inc.
- Industry
- Eligibility
- 18 Years to 75 Years
- Enrollment
- 478 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2008 – 2010
- U.S. locations
- 25
- States / cities
- Little Rock, Arkansas • Cerritos, California • Oceanside, California + 20 more
- Conditions
- Schizophrenia
- Interventions
- SCA-136 (200 mg), SCA-136 (400 mg), olanzapine (15 mg), placebo
- Drug
- Lead sponsor
- Wyeth is now a wholly owned subsidiary of Pfizer
- Industry
- Eligibility
- 18 Years to 65 Years
- Enrollment
- 300 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2006 – 2007
- U.S. locations
- 35
- States / cities
- Little Rock, Arkansas • Cerritos, California • Costa Mesa, California + 29 more
- Conditions
- Patients With Schizophrenia and Acute Agitation
- Interventions
- Inhaled loxapine 5 mg, Inhaled loxapine 10 mg, Inhaled placebo
- Drug
- Lead sponsor
- Alexza Pharmaceuticals, Inc.
- Other
- Eligibility
- 18 Years to 65 Years
- Enrollment
- 344 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2008
- U.S. locations
- 1
- States / cities
- Atlanta, Georgia
- Conditions
- Schizophrenia, Schizoaffective Disorder, Bipolar Disorder
- Interventions
- Not listed
- Lead sponsor
- Northwell Health
- Other
- Eligibility
- 18 Years and older
- Enrollment
- 106 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2013 – 2015
- U.S. locations
- 1
- States / cities
- Glen Oaks, New York
- Conditions
- Schizophrenia
- Interventions
- SEP-363856 50mg, SEP-363856 75mg, Placebo
- Drug
- Lead sponsor
- Otsuka Pharmaceutical Development & Commercialization, Inc.
- Industry
- Eligibility
- 13 Years to 65 Years
- Enrollment
- 463 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2019 – 2023
- U.S. locations
- 18
- States / cities
- Little Rock, Arkansas • Anaheim, California • Bellflower, California + 13 more
- Conditions
- Tobacco Dependence, Cigarette Craving, Smoking Behavior
- Interventions
- Exercise, passive control
- Behavioral
- Lead sponsor
- Brown University
- Other
- Eligibility
- 18 Years to 60 Years
- Enrollment
- 30 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2012 – 2015
- U.S. locations
- 1
- States / cities
- Providence, Rhode Island
- Conditions
- Schizophrenia
- Interventions
- Placebo, Cariprazine, Risperidone
- Drug
- Lead sponsor
- Forest Laboratories
- Industry
- Eligibility
- 18 Years to 60 Years
- Enrollment
- 732 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2008 – 2009
- U.S. locations
- 18
- States / cities
- Costa Mesa, California • Long Beach, California • Oceanside, California + 14 more
- Conditions
- Psychosis, Anxiety, Depression, Behavioral and Psychiatric Symptoms of Dementia
- Interventions
- Behavioral Health Home Hospital
- Other
- Lead sponsor
- Brigham and Women's Hospital
- Other
- Eligibility
- 18 Years and older
- Enrollment
- 41 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2026
- U.S. locations
- 4
- States / cities
- Belmont, Massachusetts • Boston, Massachusetts • Jamaica Plain, Massachusetts
- Conditions
- Schizophrenia, Schizoaffective Disorder
- Interventions
- RO6889450, Placebo, Risperidone
- Drug
- Lead sponsor
- Hoffmann-La Roche
- Industry
- Eligibility
- 18 Years to 45 Years
- Enrollment
- 287 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2020 – 2022
- U.S. locations
- 24
- States / cities
- Little Rock, Arkansas • Bellflower, California • Culver City, California + 20 more
- Conditions
- Schizophrenia, Schizoaffective Disorder
- Interventions
- Olanzapine, Metformin, Simvastatin
- Drug
- Lead sponsor
- Duke University
- Other
- Eligibility
- 18 Years to 60 Years
- Healthy volunteers
- Accepts healthy volunteers
- Timeline
- 2008 – 2010
- U.S. locations
- 2
- States / cities
- Butner, North Carolina • Durham, North Carolina
- Conditions
- Schizophrenia
- Interventions
- Iloperidone, Ziprasidone, Placebo
- Drug
- Lead sponsor
- Vanda Pharmaceuticals
- Industry
- Eligibility
- 18 Years to 65 Years
- Enrollment
- 593 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2005 – 2007
- U.S. locations
- 33
- States / cities
- Little Rock, Arkansas • Anaheim, California • Cerritos, California + 28 more
- Conditions
- Schizophrenia
- Interventions
- ABT-925, Placebo
- Drug
- Lead sponsor
- Abbott
- Industry
- Eligibility
- 18 Years to 65 Years
- Enrollment
- 156 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2006 – 2007
- U.S. locations
- 11
- States / cities
- Anaheim, California • Cerritos, California • Garden Grove, California + 7 more
- Conditions
- Schizophrenia
- Interventions
- RBP-7000, Placebo, Risperidone
- Drug
- Lead sponsor
- Indivior Inc.
- Industry
- Eligibility
- 18 Years to 55 Years
- Enrollment
- 354 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2014
- U.S. locations
- 32
- States / cities
- Little Rock, Arkansas • Springdale, Arkansas • Cerritos, California + 25 more
- Conditions
- Schizophrenia
- Interventions
- Placebo, ML-007C-MA BID, ML-007C-MA QD
- Drug
- Lead sponsor
- MapLight Therapeutics
- Industry
- Eligibility
- 18 Years to 64 Years
- Enrollment
- 307 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2025 – 2026
- U.S. locations
- 24
- States / cities
- Little Rock, Arkansas • Bellflower, California • Culver City, California + 21 more
- Conditions
- Schizophrenia
- Interventions
- PF-02545920, Placebo, Risperidone
- Drug
- Lead sponsor
- Pfizer
- Industry
- Eligibility
- 18 Years to 65 Years
- Enrollment
- 259 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2010 – 2011
- U.S. locations
- 38
- States / cities
- Little Rock, Arkansas • Anaheim, California • Escondido, California + 23 more
- Conditions
- Acute Schizophrenia
- Interventions
- OPC-34712, Placebo
- Drug
- Lead sponsor
- Otsuka Pharmaceutical Development & Commercialization, Inc.
- Industry
- Eligibility
- 18 Years to 65 Years
- Enrollment
- 674 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2011 – 2014
- U.S. locations
- 19
- States / cities
- Little Rock, Arkansas • Springdale, Arkansas • Escondido, California + 15 more
- Conditions
- Bipolar I Disorder, Bipolar II Disorder, Schizophrenia, Schizoaffective Disorder, Schizophreniform Disorders, Psychomotor Agitation
- Interventions
- BXCL501 Sublingual Film
- Drug
- Lead sponsor
- BioXcel Therapeutics Inc
- Industry
- Eligibility
- 18 Years to 75 Years
- Enrollment
- 33 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2025
- U.S. locations
- 5
- States / cities
- Chino, California • Oceanside, California • Orange, California + 2 more
- Conditions
- Schizophrenia
- Interventions
- LB-102
- Drug
- Lead sponsor
- LB Pharmaceuticals Inc.
- Industry
- Eligibility
- 18 Years to 55 Years
- Enrollment
- 359 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2023 – 2024
- U.S. locations
- 25
- States / cities
- Bentonville, Arkansas • Little Rock, Arkansas • Rogers, Arkansas + 20 more
- Conditions
- Schizophrenia
- Interventions
- LB-102 (50 mg tablet), LB-102 (100 mg tablet), Placebo
- Drug · Other
- Lead sponsor
- LB Pharmaceuticals Inc.
- Industry
- Eligibility
- 18 Years to 65 Years
- Enrollment
- 456 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2026 – 2027
- U.S. locations
- 13
- States / cities
- Bentonville, Arkansas • Little Rock, Arkansas • Culver City, California + 9 more
- Conditions
- Schizophrenia, Acute Episode
- Interventions
- Elpipodect, Risperidone, Placebo matching MK-8189, Placebo matching risperidone
- Drug
- Lead sponsor
- Merck Sharp & Dohme LLC
- Industry
- Eligibility
- 18 Years to 50 Years
- Enrollment
- 224 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2017 – 2018
- U.S. locations
- 28
- States / cities
- Little Rock, Arkansas • Rogers, Arkansas • Bellflower, California + 23 more
- Conditions
- Schizophrenia
- Interventions
- LY2140023, Placebo
- Drug
- Lead sponsor
- Denovo Biopharma LLC
- Industry
- Eligibility
- 18 Years to 65 Years
- Enrollment
- 567 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2011 – 2012
- U.S. locations
- 1
- States / cities
- Wichita, Kansas